These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6935180)

  • 21. Environmental cancer: animal studies and assay procedures.
    Griffin AC
    Tex Rep Biol Med; 1978; 37():45-9. PubMed ID: 752984
    [No Abstract]   [Full Text] [Related]  

  • 22. [The methodology of an experimental study of the carcinogenicity of jointly acting chemical agents].
    Katul'skiĭ IuN
    Vopr Onkol; 1990; 36(7):785-91. PubMed ID: 2399657
    [No Abstract]   [Full Text] [Related]  

  • 23. Fundamental carcinogenic processes and their implications for low-dose risk assessment.
    Mantel N
    Cancer Res; 1978 Jun; 38(6):1835-8. PubMed ID: 647692
    [No Abstract]   [Full Text] [Related]  

  • 24. Design of cancer assays for pharmaceutical agents.
    Meyers DB; Young SS; Gries CL
    J Natl Cancer Inst; 1985 May; 74(5):1151-2. PubMed ID: 3858583
    [No Abstract]   [Full Text] [Related]  

  • 25. Scientific bases for identification of potential carcinogens and estimation of risks. Interagency Regulatory Liaison Group, Work Group on Risk Assessment.
    Annu Rev Public Health; 1980; 1():345-93. PubMed ID: 6753864
    [No Abstract]   [Full Text] [Related]  

  • 26. Considerations in the conduct of meta-analysis using data from animal carcinogenicity experiments.
    McKnight B
    IARC Sci Publ; 1992; (116):557-69. PubMed ID: 1428098
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of animal carcinogenicity studies for goodness-of-fit of multistage models.
    Portier CJ; Hoel DG
    Fundam Appl Toxicol; 1984 Dec; 4(6):949-59. PubMed ID: 6519375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of data from short-term tests in the evaluation of the carcinogenicity of environmental chemicals to humans.
    Yamasaki H; Wilbourn JD; Haroun L
    Prog Clin Biol Res; 1982; 109():169-80. PubMed ID: 7167540
    [No Abstract]   [Full Text] [Related]  

  • 30. [The current requirements for the preclinical study of the safety of new drugs].
    Arzamastsev EV; Liubimov BI
    Eksp Klin Farmakol; 1995; 58(3):7-12. PubMed ID: 7663306
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of non-mammalian species in bioassays for carcinogenicity.
    Bunton TE
    IARC Sci Publ; 1999; (146):151-84. PubMed ID: 10353387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status and future directions of chemosensitivity testing.
    Sevin BU; Perras JP; Köchli OR
    Contrib Gynecol Obstet; 1994; 19():179-94. PubMed ID: 7995049
    [No Abstract]   [Full Text] [Related]  

  • 33. The scientific basis for short-term tests for carcinogenicity: non-mammalian systems.
    Green MH
    IARC Sci Publ; 1980; (27):155-67. PubMed ID: 7002777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of tests for carcinogenicity.
    Purchase IF
    IARC Sci Publ; 1980; (27):343-9. PubMed ID: 7002781
    [No Abstract]   [Full Text] [Related]  

  • 35. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
    Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2nd International symposium of the Society of Toxicologic Pathologists. Design of carcinogenicity studies: considerations in pathology interpretation. May 9-11, 1983, Arlington, Virginia.
    Toxicol Pathol; 1983; 11(1):28-95. PubMed ID: 6681393
    [No Abstract]   [Full Text] [Related]  

  • 37. The assessment of low-dose carcinogenicity.
    Armitage P
    Biometrics; 1982 Mar; 38 Suppl():119-39. PubMed ID: 7046818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and D-mannitol.
    Lina BA; Woutersen RA; Bruijntjes JP; van Benthem J; van den Berg JA; Monbaliu J; Thoolen BJ; Beems RB; van Kreijl CF
    Toxicol Pathol; 2004; 32(2):192-201. PubMed ID: 15200157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of dose and time in a long-term, low-dose carcinogenic study.
    Littlefield NA; Farmer JH; Gaylor DW; Sheldon WG
    J Environ Pathol Toxicol; 1980; 3(3 Spec No):17-34. PubMed ID: 7365379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of statistical methodologies used to compare (bio)assays.
    Dewé W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2208-13. PubMed ID: 19246258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.